Our present date showed the treatment of HCCs with SDSR plus hepatic artery embolization and infusion has an exact curative effect.
充分显示出立体 定向适形放疗联合肝动脉灌注对中晚期肝癌的良好效果。
The enhancement of HCCs in the vascular phase was analyzed according to the degree of pathological differentiation obtained by fine-needle biopsy.
所有病例均经细针穿刺活检明确病理分化程度，并分析相应血管相肝癌的增强方式。
Methods:5 small hepatocellular carcinomas(HCCs) and 3 hepatic metastatic carcinomas(HMCs) were performed chemo ablation of PAI under the CT guidance.
方法：5例小肝癌、3例肝转移癌在CT引导下经皮乙酸注射化学灭活术。
Conclusion: The MR dynamic curves and contrast enhancement ratio may prove useful in estimating angiogenic activity and indicating prognosis in HCCs.
结论：肝细胞癌的磁共振动态增强曲线和对比增强率能够反映肿瘤微血管形成程度，从而有助于判断病人的预后。
By analyzed with immunohistochemistry in 45 HCCs, the MMP-1 expression in HCCs with invasion or metastasis is higher than that without invasion and metastasis (P0.05).
在45例肝癌组织中，应用免疫组织化学分析显示，高侵袭组MMP - 1表达明显高于低侵袭组(P 0.05)。
By analyzed with immunohistochemistry in 45 HCCs, the MMP-1 expression in HCCs with invasion or metastasis is higher than that without invasion and metastasis (P0.05).
在45例肝癌组织中，应用免疫组织化学分析显示，高侵袭组MMP - 1表达明显高于低侵袭组(P 0.05)。
应用推荐